Biology of metabolic syndrome in a vascular patient (Q38018900)

27 August 2017

Biology of metabolic syndrome in a vascular patient (English)

1 reference

27 August 2017

1 reference

Daynene Vykoukal

1

1 reference

PubMed ID

22700582

27 August 2017

Mark G Davies

series ordinal

2

1 reference

27 August 2017

14 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

20

1 reference

27 August 2017

3

1 reference

27 August 2017

156-165

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

27 August 2017

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Obesity-induced inflammatory changes in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Impact of obesity on outcomes after open surgical and endovascular abdominal aortic aneurysm repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Hepatic insulin resistance, metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

The autocrine and paracrine roles of adipokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Association of adiponectin levels and insulin demand in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Obesity-associated hypertension: new insights into mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Obesity and kidney disease: a big dilemma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Obesity, insulin resistance and kidney disease risk: insights into the relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Effect of posttraumatic hyperglycemia on contusion volume and neutrophil accumulation after moderate fluid-percussion brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Role of adipose tissue in haemostasis, coagulation and fibrinolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Thrombospondins as matricellular modulators of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

The role of thrombospondin-1 in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Venous thromboembolism in association with features of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Monocyte chemoattractant protein 1 in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Impact of metabolic syndrome on clinical and angiographic outcome after sirolimus-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the "Progetto ATENA" study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome relates to lacunar stroke without white matter lesions: a study in first-ever lacunar stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

The adverse prognostic significance of the metabolic syndrome with and without hypertension in patients who underwent complete coronary revascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Obesity and impaired renal function: potential for lifestyle intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FVASC.2011.201201

21 January 2018

Identifiers

DOI

10.1258/VASC.2011.201201

1 reference

27 August 2017

1 reference

PubMed ID

22700582